Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
---|---|---|---|---|---|
EP2637664B1 | 29 Mar, 2017 | Compositions And Methods Of Treating Pulmonary Hypertension | Oct, 2031 | 6 | |
EP3150586B1 | 08 Jan, 2020 | Modulators Of Pharmacokinetic Properties Of Therapeutics | NA | 3 | |
EP3346995B1 | 28 Aug, 2019 | Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus | NA | 3 | |
EP2682397B1 | 19 Apr, 2017 | Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same | NA | 3 | |
EP2655623B2 | 30 Aug, 2023 | Non-Coding Immunomodulatory Dna Construct | NA | 1 | |
EP4070788B1 | 22 Mar, 2023 | Pharmaceutical Formulations | Jun, 2036 | 1 | |
EP4070787B1 | 01 Mar, 2023 | Pharmaceutical Formulations | Jun, 2036 | 1 | |
EP3157932B1 | 10 Jan, 2018 | Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate | Jun, 2035 | 1 |